What this record means
The record shows that the mark “XCELLDERMA” is currently pending on the Principal Register, owned by Regenerex Pharma, Inc., a Nevada corporation. The application was filed on December 5, 2025 and the most recent status update, a non‑final Office action, was issued on April 21, 2026. The mark covers pharmaceutical preparations for wound care, including wound dressings and healing preparations, as listed in class 005. A similar name used in the same or closely related medical or pharmaceutical context would raise the closest concern. The record does not give the mark control over every use of the wording; it is limited to the goods and services described. No enforcement activity—oppositions, cancellations, or court actions—is visible in the supplied history. The next consequential date would be the response deadline to the Office action, but that date is not provided. For someone considering a similar name, the pending status and specific wound‑care focus suggest a meaningful risk of conflict in that area.
Informational only - not legal advice.Goods & services
medical preparations, namely, wound care preparations; antiseptic preparations for medical, surgical and veterinary use; pharmaceutical preparations for wound care for application to necrotic wounds, ulcers, surgical wounds, burns, graft sites and cavity wounds; wound dressings; dressing materials for wounds, namely, medical pharmaceutical preparations for wound care in the nature of wound healing and wound care preparations and dressings; pharmaceutical preparations for wound care in the nature of wound healing and wound care preparations and dressings to help reduce wound odor; pharmaceutical preparations for wound care in the nature of wound healing and wound care preparations and dressings to help maintain an antiseptic wound healing environment
